Overview

Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)

Status:
Completed
Trial end date:
2001-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and local toleration and histological effects of various dose levels of avotermin (Juvista) injected intradermally in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Renovo